AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -71.4% | 59,879 | -26.7% | 0.00% | – |
| Q2 2022 | $14,000 | -63.2% | 81,729 | +2.2% | 0.00% | – |
| Q1 2022 | $38,000 | -9.5% | 79,964 | +8.8% | 0.00% | – |
| Q4 2021 | $42,000 | -74.2% | 73,514 | -25.0% | 0.00% | – |
| Q3 2021 | $163,000 | -9.9% | 98,043 | -9.7% | 0.00% | – |
| Q2 2021 | $181,000 | +70.8% | 108,564 | +73.3% | 0.00% | – |
| Q1 2021 | $106,000 | -1.9% | 62,650 | -7.9% | 0.00% | – |
| Q4 2020 | $108,000 | +38.5% | 68,050 | -16.3% | 0.00% | – |
| Q3 2020 | $78,000 | +59.2% | 81,300 | +6.3% | 0.00% | – |
| Q2 2020 | $49,000 | +16.7% | 76,500 | -23.9% | 0.00% | – |
| Q1 2020 | $42,000 | -20.8% | 100,500 | +10.7% | 0.00% | – |
| Q4 2019 | $53,000 | +17.8% | 90,791 | 0.0% | 0.00% | – |
| Q3 2019 | $45,000 | +32.4% | 90,791 | +2.8% | 0.00% | – |
| Q2 2019 | $34,000 | -48.5% | 88,352 | +194.5% | 0.00% | – |
| Q2 2018 | $66,000 | -35.3% | 30,000 | 0.0% | 0.00% | – |
| Q1 2018 | $102,000 | -11.3% | 30,000 | +6.4% | 0.00% | – |
| Q4 2017 | $115,000 | +2200.0% | 28,200 | +176.5% | 0.00% | – |
| Q2 2017 | $5,000 | -37.5% | 10,200 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | -20.0% | 10,200 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | +25.0% | 10,200 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | -33.3% | 10,200 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | -78.2% | 10,200 | -50.0% | 0.00% | – |
| Q1 2016 | $55,000 | -20.3% | 20,400 | -6.4% | 0.00% | – |
| Q4 2015 | $69,000 | +35.3% | 21,800 | +24.4% | 0.00% | – |
| Q3 2015 | $51,000 | +8.5% | 17,525 | -10.3% | 0.00% | – |
| Q2 2015 | $47,000 | -56.5% | 19,531 | +36.8% | 0.00% | -100.0% |
| Q1 2015 | $108,000 | +200.0% | 14,281 | +37.3% | 0.00% | – |
| Q4 2014 | $36,000 | -35.7% | 10,400 | -34.1% | 0.00% | – |
| Q3 2014 | $56,000 | -54.1% | 15,775 | +8.0% | 0.00% | -100.0% |
| Q2 2014 | $122,000 | +41.9% | 14,600 | +8.3% | 0.00% | 0.0% |
| Q1 2014 | $86,000 | -86.3% | 13,484 | -84.6% | 0.00% | -75.0% |
| Q4 2013 | $626,000 | +18.6% | 87,760 | +28.5% | 0.00% | 0.0% |
| Q3 2013 | $528,000 | +34.0% | 68,276 | 0.0% | 0.00% | +33.3% |
| Q2 2013 | $394,000 | – | 68,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVA Family Office, LLC | 1,173,200 | $1,865,000 | 1.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $1,387,000 | 0.82% |
| Cypress Capital Management LLC (WY) | 214,575 | $341,000 | 0.30% |
| Western Wealth Management, LLC | 982,350 | $1,562,000 | 0.23% |
| SRS Capital Advisors, Inc. | 615,659 | $979,000 | 0.14% |
| Willis Investment Counsel | 1,213,053 | $1,929,000 | 0.13% |
| Harvest Investment Services, LLC | 124,423 | $197,000 | 0.10% |
| Transform Wealth, LLC | 205,481 | $327,000 | 0.07% |
| COURIER CAPITAL LLC | 379,973 | $604,000 | 0.07% |
| BRIGHTON JONES LLC | 398,912 | $634,000 | 0.04% |